Blog

American Society of Clinical Oncology; Clinical Cancer Advances 2018: ASCO's Annual Report on Progress Against Cancer
February 20, 2018 Greg Guthrie, ASCO staff
El informe Avances clínicos en oncología del año 2018 de la American Society of Clinical Oncology ha adjudicado su título de Avance del año a una inmunoterapia celular adoptiva. ¿De qué se trata este tratamiento innovador contra el cáncer? ¿Cuáles son los riesgos y los beneficios? Read More
February 16, 2018 Greg Guthrie, ASCO staff
In this podcast, Cancer.Net Specialty Editor Dr. Timothy Gilligan discusses some of the quality-of-life research featured at the 2018 Cancer Survivorship Symposium: Advancing Care and Research. Read More
February 14, 2018 Greg Guthrie, ASCO staff
In this podcast, Dr. Gary Lyman describes biosimilars for cancer treatment and why they are important. He also talks about why ASCO is releasing a statement on them today. Read More
February 14, 2018 Laura Porter, MD
ASCO and NCCN have worked together to help clinicians and patients identify and treat the side effects of immunotherapy before they become dangerous. Doctor and patient advocate Laura Porter describes what to watch out for if you’re taking an immune checkpoint inhibitor, a type of immunotherapy, for cancer. Read More
Cancer Survivorship Symposium: Advancing Care and Research. A primary care and oncology collaboration.
February 12, 2018 Greg Guthrie, ASCO staff
The 2018 Cancer Survivorship Symposium: Advancing Care and Research will address key issues in promoting well-being in people who have finished active cancer treatment, covering topics such as exercise, follow-up care in young adult survivors, and better support for sexual problems. Read More

Pages